Multiple Hh target genes, including stem cell markers (CD44 and CD133), epithelial–mesenchymal transition (EMT) transcription factors and drug resistance-associated ABC proteins, contribute to drug resistance in the treatment of HCC [65]. This evidence concerns the gene CD44 and hepatocellular carcinoma.